Cambridge, USA-based biotech Oak Hill Bio this morning announced plans to go public via a combination with RA Capital-backed ...
Shares of US biotech Forte Biosciences shot up nearly 40% to $76.40 in early trading, on the news of a takeover bid from ...
US clinical-stage US autoimmune drug developerKyverna Therapeutics (Nasdaq: KYTX) and ElevateBio, a contract development and manufacturing organization (CDMO), today announced a manufacturing ...
Three weeks after the UK launch of Danish pharma major Novo Nordisk’s (NOV: N) daily Wegovy Pill (semaglutide), weight health provider CheqUp says early demand indicates strong consumer interest in a ...
US biotech Outlook Therapeutics revealed that the US Food and Drug Administration (FDA) has approved Lytenava ...
UK-based Novogene Europe, a multiomics research services partner, today announced that it has expanded its single-cell RNA ...
Among significant news last week, Halozyme Therapeutics struck a license agreement for its INCA033989 with fellow USA-based ...
The US unit of Japan’s Otsuka (TYO: 4578) has been granted US Food and Drug Administration (FDA) approval for Simtriyo (centanafadine), a once-daily extended-release capsule for the treatment of ...
The European Medicines Agency’s (EMA) human medicines committee (CHMP) today announced recommendations for the approval of ...
French pharma major Sanofi (Euronext: SAN) today announced the discontinuation of clinical development of amlitelimab, an OX40-ligand monoclonal antibody, in moderate-to-severe atopic dermatitis (AD).
US pharma major Johnson & Johnson has reported positive top-line Phase III data showing that a dual bispecific antibody ...
Spanish medical dermatology company Almirall (BME: ALM) has reported first-half 2026 net sales of 602.7 million euros ($687.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results